Skip to main content
SpringerLink
Log in

Physicians’ Perceptions of Risks and Practices in Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Hospitalized inflammatory bowel disease (IBD) patients are at a higher risk of venous thromboembolism (VTE).

Aims

We aimed to determine perceptions of VTE risks and self-reported practices regarding VTE prophylaxis in hospitalized IBD patients among American gastroenterologists.

Methods

Gastroenterologists who were members of the American Gastroenterological Association (AGA) and cared for IBD patients in the preceding 12 months were included. A survey assessed physicians’ perceptions of VTE risks and their practices regarding VTE prophylaxis among IBD inpatients and other factors that may influence the decision to provide prophylaxis.

Results

A total of 135 eligible gastroenterologists responded to the survey, 77 % of whom practiced in academic settings. Most physicians (84 %) reported having had IBD patients develop VTE. Only 67 % cared for IBD patients in hospitals that had protocols for VTE prophylaxis, and 45 % were aware of any published guidelines for VTE prophylaxis in hospitalized IBD patients. While only 7 % believed that any rectal bleeding was a contraindication to VTE chemoprophylaxis in hospitalized IBD patients with flares, 14 % never administered prophylaxis to IBD inpatients. A significant number of respondents felt that hospitalized IBD patients who were ambulatory (24 %) or in remission (28 %) did not require VTE prophylaxis. There was wide variation on recommendations for duration of anticoagulation for a first unprovoked VTE in an IBD patient.

Conclusions

There is significant variation in reported practices for VTE prophylaxis in IBD patients among gastroenterologists. A more standardized approach to VTE prophylaxis should be implemented to improve health outcomes for IBD inpatients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

IBD:

Inflammatory bowel disease

VTE:

Venous thromboembolism

References

  1. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430–434.

    PubMed  CAS  Google Scholar 

  2. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657–663.

    Article  PubMed  Google Scholar 

  3. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004;53:542–548.

    Article  PubMed  CAS  Google Scholar 

  4. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272–2280.

    Article  PubMed  Google Scholar 

  5. Novacek G, Weltermann A, Sobala A, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology. 2010;139:779–787.

    Article  PubMed  Google Scholar 

  6. Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97–101.

    Article  PubMed  Google Scholar 

  7. Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332:325–329.

    Article  PubMed  CAS  Google Scholar 

  8. Goldhaber SZ, Tapson VF, Committee DFS. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004;93:259–262.

    Article  PubMed  Google Scholar 

  9. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e195S–e226S.

    Article  PubMed  CAS  Google Scholar 

  10. Monreal M, Kakkar AK, Caprini JA, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost. 2004;2:1892–1898.

    Article  PubMed  CAS  Google Scholar 

  11. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132:936–945.

    Article  PubMed  Google Scholar 

  12. Maynard G, Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis. 2010;29:159–166.

    Article  PubMed  Google Scholar 

  13. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916–924.

    Article  PubMed  CAS  Google Scholar 

  14. Bernstein CN, Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol. 2007;21:507–511.

    PubMed  Google Scholar 

  15. Shen J, Ran ZH, Tong JL, et al. Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis. Aliment Pharmacol Ther. 2007;26:653–663.

    Article  PubMed  CAS  Google Scholar 

  16. Bauer KA, Eriksson BI, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001;345:1305–1310.

    Article  PubMed  CAS  Google Scholar 

  17. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S–453S.

    Article  PubMed  CAS  Google Scholar 

  18. Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874–879.

    Article  PubMed  CAS  Google Scholar 

  19. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793–800.

    Article  PubMed  CAS  Google Scholar 

  20. Wein L, Wein S, Haas SJ, et al. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1476–1486.

    Article  PubMed  CAS  Google Scholar 

  21. O’Connor OJ, Cahill RA, Kirwan WO, et al. The incidence of postoperative venous thrombosis among patients with ulcerative colitis. Ir J Med Sci. 2005;174:20–22.

    Article  PubMed  Google Scholar 

  22. Bitton A, Buie D, Enns R, Feagan BG, et al. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol. 2012;107:179–194.

    Article  PubMed  CAS  Google Scholar 

  23. Lederle FA, Zylla D, MacDonald R, Wilt TJ. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2011;155:602–615.

    PubMed  Google Scholar 

  24. Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P. Physicians CGCotACo. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;155:625–632.

    PubMed  Google Scholar 

  25. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571–607.

    Article  PubMed  Google Scholar 

  26. Kornbluth A, Sachar DB. Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501–523.

    Article  PubMed  Google Scholar 

  27. Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis. 2010;4:63–101.

    Article  PubMed  Google Scholar 

  28. Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the management of ulcerative colitis:current management. J Crohns Colitis. 2008;2:24–62.

    Article  PubMed  CAS  Google Scholar 

  29. American Gastroenterological Association. Adult inflammatory bowel disease physician performance measures set. http://www.gastro.org/practice/quality-initiatives/IBD_Measures.pdf. Retrieved August 9, 2012.

  30. Tinsley A, Naymagon S, Trindade AJ, Sachar DB, Sands BE, Ullman TA. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol. 2012. (Epub ahead of print). doi:10.1097/MCG.0b013e31824c0dea.

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, 600 University Ave, Suite 437, Toronto, ON, M5G 1X5, Canada

    Justina J. Sam, Roshan Razik, Reka Thanabalan & Geoffrey C. Nguyen

  2. IBD Clinical and Research Centre, University of Manitoba, Winnipeg, MB, Canada

    Charles N. Bernstein

Authors
  1. Justina J. Sam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles N. Bernstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roshan Razik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reka Thanabalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Geoffrey C. Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geoffrey C. Nguyen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sam, J.J., Bernstein, C.N., Razik, R. et al. Physicians’ Perceptions of Risks and Practices in Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease. Dig Dis Sci 58, 46–52 (2013). https://doi.org/10.1007/s10620-012-2435-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2435-6

Keywords

Search

Navigation